PYRROLO[2,3-b]PYRIDINE DERIVATIVE ACTIVE AS KINASE INHIBITOR, PREPARATION METHOD OF THE SAME, AND PHARMACEUTICAL PRODUCT COMPRISING THE SAME

PYRROLO[2,3-b]PYRIDINE DERIVATIVE ACTIVE AS KINASE INHIBITOR, PREPARATION METHOD OF THE SAME, AND PHARMACEUTICAL PRODUCT COMPRISING THE SAME

PROBLEM TO BE SOLVED: To provide new compounds useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.SOLUTI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GIORDANO PATRIZIA, MARTINA KATIA, BOYD EDWARD ANDREW, TRIGG WILLIAM JOHN, LARARD JONATHAN ANTHONY, D'ANELLO MATTEO, BROOKFIELD FREDERICK ARTHUR, TESEI DANIA, BRASCA MARIA GABRIELLA, SALOM BARBARA
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide new compounds useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.SOLUTION: The present invention discloses compounds of pyrrolo[2,3-b]pyridine derivatives or their pharmaceutically acceptable salts, and preparation processes of the compounds and pharmaceutical compositions comprising the compounds. The invention also discloses processes under SPS conditions for preparing the compounds, and chemical libraries comprising a great number of the compounds.